Free Trial

China SXT Pharmaceuticals (SXTC) SEC Filings & 10K Form

China SXT Pharmaceuticals logo
$0.47
-0.06 (-11.32%)
(As of 12:20 PM ET)

Recent China SXT Pharmaceuticals SEC Filings

DateFilerForm TypeView
10/25/2024
11:19 AM
China SXT Pharmaceuticals (Subject)
Streeterville Capital LLC (Filed by)
Form SC 13G/A
10/22/2024
3:51 PM
China SXT Pharmaceuticals (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/15/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
8:45 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G/A
08/13/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
3:15 PM
China SXT Pharmaceuticals (Filer)
Form NT 20-F
05/31/2024
9:36 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G/A
04/05/2024
8:25 AM
China SXT Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
9:14 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G/A
02/09/2024
5:36 AM
China SXT Pharmaceuticals (Subject)
Forsakringsaktiebolaget Avanza Pension (Filed by)
Form SC 13G
01/11/2024
3:31 PM
China SXT Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SXTC) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners